Skip to main content
. 2021 Aug 20;11(8):813. doi: 10.3390/jpm11080813

Figure 3.

Figure 3

Plateletworks® analysis between patients sensitive to 81 mg of ASA (n = 30), and ASA non-sensitive (n = 10) using platelet activation agonists (A) arachidonic acid, (B) collagen, and (C) adenosine 5’-diphosphate (ADP). Error bars represent standard error of the mean. Dotted line represents maximal aggregation in control patients not taking 81 mg of ASA. * represents p < 0.05; *** represents p < 0.001; and **** represents p < 0.0001.